Tucuvi, an AI care management company, announced it is joining the Microsoft for Startups Pegasus Program, which connects companies to Microsoft's enterprise customer ecosystem and go-to-market channels.

For Tucuvi, the selection comes at a pivotal moment as the company scales its platform across health systems. Through Pegasus, Tucuvi will be able to bring its clinically-governed approach to AI care management to more organizations, helping them move beyond point solutions and deploy patient-facing AI across both administrative and clinical workflows on a single platform.

Health systems and life sciences companies can contract Tucuvi directly through Microsoft Marketplace or apply that spend against the Microsoft Azure commitment they have already made to Microsoft, turning a new vendor evaluation into a purchase against budget that is already allocated, through a procurement path their organization has already approved.

Health systems evaluating patient-facing AI increasingly need one platform that can support both patient access, such as scheduling, navigation and referral routing, and clinical enablement, like care-gap closure, medication adherence, transitions of care, monitoring and follow-up.

These are fundamentally different problems. In access, success means getting patients to the right service. In clinical care, AI must reliably follow protocols, capture clinically relevant information, and escalate the right cases to clinicians.

Tucuvi was built from the clinical side and expanded into access. Today, more than 80 health settings run 50+ workflow types on the platform.

Tucuvi Health Manager is Tucuvi's AI care management platform. At its core is LOLA, a clinical voice AI agent that holds inbound and outbound phone conversations with patients in natural language. LOLA follows configurable clinical and administrative protocols, captures structured information, and escalates cases when human intervention is required. The platform is omnichannel, extending the same workflows to text when needed.